Arterial blood O2 levels are detected by specialized sensory organs called carotid bodies. Voltage-gated Ca(2+) channels (VGCCs) are important for carotid body O2 sensing. Given that T-type VGCCs contribute to nociceptive sensation, we hypothesized that they participate in carotid body O2 sensing. The rat carotid body expresses high levels of
mRNA encoding the α1H-subunit, and α1H
protein is localized to glomus cells, the primary O2-sensing cells in the chemoreceptor tissue, suggesting that CaV3.2 is the major T-type VGCC
isoform expressed in the carotid body.
Mibefradil and
TTA-A2, selective blockers of the T-type VGCC, markedly attenuated elevation of
hypoxia-evoked intracellular Ca(2+) concentration, secretion of
catecholamines from glomus cells, and sensory excitation of the rat carotid body. Similar results were obtained in the carotid body and glomus cells from CaV3.2 knockout (Cacna1h(-/-)) mice. Since
cystathionine-γ-
lyase (CSE)-derived H2S is a critical mediator of the carotid body response to
hypoxia, the role of T-type VGCCs in H2S-mediated O2 sensing was examined. Like
hypoxia,
NaHS, a H2S donor, increased intracellular Ca(2+) concentration and augmented carotid body sensory nerve activity in wild-type mice, and these effects were markedly attenuated in Cacna1h(-/-) mice. In wild-type mice,
TTA-A2 markedly attenuated glomus cell and carotid body sensory nerve responses to
hypoxia, and these effects were absent in CSE knockout mice. These results demonstrate that CaV3.2 T-type VGCCs contribute to the H2S-mediated carotid body response to
hypoxia.